Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
220 participants
INTERVENTIONAL
2025-12-01
2027-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Does AI-assisted rehabilitation among frail adults improve patients' physical outcomes? Is there a particular subgroup of frail subjects that will benefit most from AI-assisted rehabilitation?
Researchers will compare AI-assisted rehabilitation to standard practice (advice and QR link for rehabilitation videos to be done at home) to see if AI-assisted rehabilitation improves clinical outcomes compared to standard practice.
Participants will either:
Undergo an AI-assisted rehab with the AI-sensor tool or a standard practice post-discharge from community hospitals for 12 weeks.
Undergo interval assessments of outcomes. Keep a diary of outpatient rehabilitations (if applicable for the subjects).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multi-component Real-time Remote Rehabilitation in Sarcopenia
NCT06937073
Self-Practicing Upper Body Exercises with a Robotic Trainer System
NCT06690658
Mobility in Older People
NCT01910740
Effects of Backward Gait Training With Exoskeleton on Motor Functions
NCT05133362
Effects of Overground Robot-Assisted Gait Training on Stroke-Related Sarcopenia
NCT06910254
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Usual care
Verbal and written discharge summary, advice, and referral to outpatient physiotherapy (if applicable)
usual care only
Verbal and written discharge summary, advice, and referral to outpatient physiotherapy (if applicable)
AI-assisted rehabilitation
AI-assisted rehabilitation on top of usual care
AI-assisted rehabilitation
Receives AI-assisted rehabilitation post-discharge at home in addition to usual care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AI-assisted rehabilitation
Receives AI-assisted rehabilitation post-discharge at home in addition to usual care
usual care only
Verbal and written discharge summary, advice, and referral to outpatient physiotherapy (if applicable)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical Frailty Score (CFS) 4 to 6 \*
* Provided informed consent (for cognitively impaired persons MMSE\<18, next-of-kin or proxy to give consent).
* Have access to smartphone/tablet (own or loaned from investigators)/
Exclusion Criteria
* Cognitive impairment (MMSE\<18) and no caregiver to assist with use of tool.
* Participation in structured outpatient physiotherapy (\>1 times/week), or day rehab programme.
21 Years
120 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jurong Community Hospital, Singapore
UNKNOWN
SingHealth Community Hospitals
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ong Chong Yau
Doctor
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-1300
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.